Covid-19 roundup: Manufacturing contract axed for Valneva’s vaccine; Penny stock halts early infection trial
French vaccine company Valneva and German CDMO IDT Biologika have decided to terminate their manufacturing collaboration for Valneva’s Covid-19 vaccine.
IDT Biologika was originally tasked with making Valneva’s VLA2001 vaccine, but the deal has been halted due to “the delivery of inactivated Covid-19 bulk vaccine to Valneva.” A statement from Valneva also lists a lack of orders and sufficient inventory as the other reasons.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.